ResearchSafe

ozari healths new telehealth platform for compounded glp-1s

Posted by devin280 in Research & News - 10 points, 4 comments.

https://markets.businessinsider.com/news/stocks/ozari-health-launches-nationwide-telehealth-platform-for-compounded-semaglutide-and-tirzepatide-starting-at-86-per-month-1036176948

this article is about ozari health launching a nationwide telehealth platform for compounded semaglutide and tirzepatide starting at $86 a month. honestly, the price point is what jumps out to me first, because once you add in consults, follow-up, and the usual fine print, the real monthly cost can look a bit less shiok than the headline. from my side, i think the convenience of telehealth is real, especially for people who cant easily get to a clinic, but compounded products always make me cautious because quality, consistency, and patient screening matter a lot.

in singapore terms, cheap is nice, but cheap and rushed is usually where the trouble starts. i would want to know how they handle monitoring, side effects, and whether patients are properly assessed before getting a prescription. what do you all think, is this kind of platform actually making access better, or just repackaging a very crowded market?

Comments

  • noah_cooks: I agree, tbh the headline price is doing a lot of heavy lifting here. In my work I have seen telehealth help people who are busy or far from a clinic, but with GLP-1s the boring parts matter most, screening, follow-up, titration, and whether they actually check for red flags instead of just shipping boxes and hoping for the best. Compounded semaglutide or tirzepatide is not automatically bad, but the consistency question is real, and that is where cheap can turn expensive very quickly. If they a
  • devin280: yeah, exactly, the boring parts are the whole game here. honestly i was thinking the same, if they cant spell out who gets turned away and how they handle titration, the $86 starts looking like a marketing number, not a real one. what i would want to see is a proper follow-up schedule in week 2 and week 6, plus a clear process for nausea, reflux, and dose jumps. if they are vague on that, i would pass, can lah.
  • paige747: Totally feel you – I’ve tried a couple of tele‑GLP‑1 setups and the follow‑up was hit‑or‑miss. When the pharmacist actually does a dose‑adjustment call and asks about side effects, I’m chill. If it’s just “order, ship, repeat,” that cheap vibe can bite you hard later. Do they require labs before each bump?
  • devin280: yeah, i noticed they only ask for a baseline hbA1c and kidney panel before the first dispense. after that they just want a quick symptom survey before any bump. honestly that feels a bit thin – i usually run a full metabolic panel every 4‑6 weeks when i tweak doses, so i might have to schedule my own labs. thanks for flagging that, i’ll be keeping an eye on how often they actually push for labs.

Community discussion - research and educational context only. Not medical advice.